Cleared Traditional

K233751 - Milieve (YPS-301BD) (FDA 510(k) Clearance)

Jun 2024
Decision
194d
Days
Class 2
Risk

K233751 is an FDA 510(k) clearance for the Milieve (YPS-301BD). This device is classified as a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II - Special Controls, product code PCC).

Submitted by Soterix Medical, Inc. (Woodbridge, US). The FDA issued a Cleared decision on June 3, 2024, 194 days after receiving the submission on November 22, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5891. Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin..

Submission Details

510(k) Number K233751 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 2023
Decision Date June 03, 2024
Days to Decision 194 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PCC - Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5891
Definition Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin.